Ares-Serono Group

Efalizumab

• Category :

  Pharmaceuticals and Biochemicals

• CAS NO :

• EC NO :

• Molecular Formula :

• Molecular Weight :

• Main Specifications :

• Product description :

  Efalizumab (Raptiva) is a humanized monoclonal antibody targeting CD11a that is undergoing review for approval for the treatment of moderate-to-severe plaque psoriasis in many countries. It was recently approved by the US FDA and is marketed in th